Biological Threat Detection Via Host Gene Expression Profiling. Biological Threat Detection Via Host Gene Expression Profiling.

Biological Threat Detection Via Host Gene Expression Profiling‪.‬

Clinical Chemistry 2003, July, 49, 7

    • $5.99
    • $5.99

Publisher Description

The task of detecting biological threats is far more complicated than monitoring for other weapons of mass destruction. Measuring and quantifying radiation and chromatographic profiles indicative of nuclear and chemical threats, respectively, are relatively straightforward compared with the detection of biological weapon threats amid the tremendous biological background that comprises our environment. Most of the current biological warfare and environmental agent detection systems in field use or under prototype development rely on structural recognition approaches to identify anticipated agents or rely on "gold standard" culture conditions. Such assays, based primarily on antibodies, are highly specific for anticipated targets but provide only partial information concerning the pathogenicity of the threat. Current systems the military has implemented for threat identification have performed with limited success. In fact, the Pentagon Inspector General has criticized the "Joint Biological Point Detection System" for erratic limited performance (1). In addition, it is unclear how such an approach is applicable to the civilian population, where mass deployment of point detectors is not a feasible solution. Even with ideal detectors, proximity to a biological threat does not guarantee infection or illness. For threats such as Bacillus anthracis, the ability to preemptively treat individuals who were near dissemination sources with antibiotics is an option, if the dissemination source can be identified. Of further concern, a report has been published of a B. anthracis vaccine strain that had been engineered by Russian scientists to resist tetracycline antibiotics (2), raising the possibility that a quinolone-resistant B. anthracis could emerge as a biological weapon threat. Thus, not all biological threats can be treated as readily as during recent events, and there is a critical need to be able to quickly discern those individuals who are ill as a result of a bioagent etiology and to yield insight to the severity of illness.

GENRE
Science & Nature
RELEASED
2003
July 1
LANGUAGE
EN
English
LENGTH
15
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
171.6
KB

More Books Like This

Gene Discovery for Disease Models Gene Discovery for Disease Models
2011
Chemical Diagnostics Chemical Diagnostics
2013
Applications of Advanced Omics Technologies: From Genes to Metabolites Applications of Advanced Omics Technologies: From Genes to Metabolites
2014
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Principles and Applications of Molecular Diagnostics Principles and Applications of Molecular Diagnostics
2018
Systems Biological Approaches in Infectious Diseases Systems Biological Approaches in Infectious Diseases
2007

More Books by Clinical Chemistry

Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs) Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs)
2005
Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry) Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry)
2008
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Transferrin Saturation and Screening of Genetic Hemochromatosis (Letters) (Letter to the Editor) Transferrin Saturation and Screening of Genetic Hemochromatosis (Letters) (Letter to the Editor)
1998
Effect of Riboflavin Status on the Homocysteine-Lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype (Nutrition) Effect of Riboflavin Status on the Homocysteine-Lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype (Nutrition)
2003